Premium Information is available for this item - Upgrade for $1 a day
6505-00-022-1323
Chlorpromazine Hydrochloride Extended-Release Capsules
6505000221323 000221323 NDC00007-5064-25 THORAZINE
June 2023
8
Marketplace 6505-00-022-1323
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-022-1323 5+ Documents (More...)
/us 6505-00-619-8388 6505006198388 006198388,TH0RAZINE 022-1323 6505000221323 000221323,NDC00007-5064
,THORAZINE Related to 6505-00-022-1324 6505-00-022-1323 6505-00-684-8672 Action Method:Extended Release
-4286 6505000221324 000221324,THORAZINE Related to 6505-00-022-1324 6505-00-022-1323 6505-00-684-8672
022-1324 6505-00-022-1323 6505-00-684-8672 6505-01-154-4286 022-1323 6505000221323 000221323,NDC00007
6505000221323 000221323,NDC00007-5064-25 Related to 6505-00-022-1323 6505-00-022-1323 6505-00-684
00-619-8388 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-022-1324 6505000221324 000221324,THORAZINE
022-1324 6505-00-022-1323 6505-00-684-8672 6505-01-154-4286 6505-00-022-1324 6505-00-619-8388 6505-00
-619-8402 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-022-1323 6505000221323 000221323,NDC00007
6505000221323 000221323,NDC00007-5064-25 022-1323 6505-00-684-8672 6505-01-154-4286 6505-00-022
01-343-3074 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-022-1324 6505000221324 000221324,THORAZINE
Restrictions 6505-00-022-1323
6505-00-022-1323 is a Chlorpromazine Hydrochloride Extended-Release Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-00-022-1323
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-022-1323
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-022-1323
- Part Number
- Manufacturer
- Status
- NDC00007-5064-25
- Manufacturer
- 93544 - Glaxosmithkline Holdings (Americas) (Obsolete)
- Original Design
- Original Design
- THORAZINE
- 93544 - Glaxosmithkline Holdings (Americas) (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-00-022-1323
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Capsule Type [AKJC]
- Any Acceptable
- Capsule Content Form [CQLS]
- Any Acceptable
- Active Medicament Medicinal Strength [AKJA]
- 75.000 Milligrams Chlorpromazine Hydrochloride Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 500.000
- Special Features [FEAT]
- Long Action Method:Extended Release;
Management Data 6505-00-022-1323
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Nov 1983
- Veterans Administration (VA)
- BT
- Subscribe
- 3
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 500 Ea
- 00000000500EA
- K
NATO Stock Numbers Related to 6505-00-022-1323
Freight Information 6505-00-022-1323
6505-00-022-1323 has freight characteristics.. 6505-00-022-1323 has a variance between NMFC and UFC when transported by rail and the description should be consulted.